Theta Burst Stimulation for Brain Connectivity Changes
Trial Summary
What is the purpose of this trial?
Transcranial magnetic stimulation (TMS) is increasingly being applied to effectively treat mental illness, however efforts to quantify the effects of TMS on the network architecture of the brain have largely been limited in scope and tied to specific neurologic and psychiatric disorders. The objective of the current work is to build and validate a whole-brain, domain-general model of brain connectivity changes following TMS, based on physical models of the current distribution at the cortex. PUBLIC HEALTH RELEVANCE: This work is relevant to public health because it will provide direct evidence that brain connectivity changes following neuromodulatory TMS vary as a function of the current density at the cortex, which can be used to predict psychiatric symptom change following neuromodulatory TMS.
Will I have to stop taking my current medications?
The trial excludes participants who are taking medications that act on the central nervous system, so you may need to stop taking such medications to participate.
What data supports the effectiveness of the treatment Theta Burst Stimulation for Brain Connectivity Changes?
Research shows that intermittent theta burst stimulation (iTBS) can improve motor function and reduce depression symptoms, suggesting it may help with brain connectivity changes. It has been effective in enhancing movement-related brain activity and reducing cortical inhibition, which are important for brain function.12345
Is theta burst stimulation safe for humans?
How is intermittent theta burst stimulation (iTBS) different from other treatments?
Intermittent theta burst stimulation (iTBS) is unique because it uses magnetic pulses to stimulate the brain, which can help improve motor function by influencing brain activity. Unlike traditional treatments, iTBS is non-invasive and specifically targets the brain's motor cortex to enhance recovery and reduce inhibition in neural networks.1241011
Research Team
Nicholas L Balderston
Principal Investigator
University of Pennsylvania
Eligibility Criteria
This trial is for right-handed individuals who can consent to participate. It's not suitable for those with recent alcohol/drug issues, medical conditions affecting fMRI or TMS safety, metal implants, claustrophobia, severe psychiatric disorders, epilepsy, pregnancy, non-English speakers, CNS medications use or any significant health problems.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive multiple doses of either intermittent or continuous theta burst stimulation (iTBS and cTBS) over 3 stimulation days, with 5 sessions per day.
Follow-up
Participants are monitored for changes in resting state functional connectivity and working memory performance 24 hours after each dose.
Treatment Details
Interventions
- Continuous Theta Burst Stimulation
- Intermittent Theta Burst Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nicholas Balderston, PhD
Lead Sponsor